ELEVANCE HEALTH INC ELV 2.75 10.15.42
NOTE 2.750%10/1 · US DOMESTIC · CUSIP 94973VBG1
2
institutional holders
-31 vs Q4 2022
13.6k
shares reported held*
$6.2mreported value*
1 new
0 added
0 reduced
32 sold out
net sold ≈ $29.1bn (-1.5m shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $459.81.
Trends to Q1 2023
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 34 |
| Q4 2022 | 33 |
| Q1 2023 | 2 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2022 | 5 | 17 |
| Q1 2023 | 1 | 32 |
Biggest buyers
| Qube Research & Technologies Ltd | New | +13.6k |
Biggest sellers
| VICTORY CAPITAL MANAGEMENT INC | Sold out | -21.3m |
| MacKay Shields LLC | Sold out | -15.0m |
| ADVENT CAPITAL MANAGEMENT /DE/ | Sold out | -7.4m |
| SSI INVESTMENT MANAGEMENT LLC | Sold out | -4.1m |
| VOYA INVESTMENT MANAGEMENT LLC | Sold out | -3.8m |
| BANK OF AMERICA CORP /DE/ | Sold out | -2.4m |
| Thrivent Financial for Lutherans | Sold out | -1.4m |
| JPMORGAN CHASE & CO | Sold out | -1.4m |
| CONNING INC. | Sold out | -1.2m |
| CQS (US), LLC | Sold out | -1.1m |
Holders, Q1 2023
| Manager | Shares | Change |
|---|---|---|
| Qube Research & Technologies Ltd 0.04% of their portfolio | 13.6k $6.2m | New |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |